ReviewTherapeutic advances in medical oncology2020

Application of immune checkpoint inhibitors in EGFR-mutant non-small-cell lung cancer: from bed to bench.

Rui Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.